Nasopharyngeal Neoplasms: all 242 studies
Page 2 of 3. Open to participants first (47), then studies with results posted, then the rest; newest registration first within each.
- Development of a Severity Assessment Score for Nasosinus Polyposis (PSI Score)CompletedNCT05056714
- A Study of JNJ-64251330 in Participants With Familial Adenomatous PolyposisCompletedNCT05014360Phase 1
- Multicenter Study on the Pathogenic Germline Gene Variants of Colorectal Polyposis in ChinaStatus unknownNCT04961125
- Post-Trial Access for Guselkumab in Participants With Familial Adenomatous PolyposisNo longer availableNCT04948398
- Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative StudiesActive, not recruitingNCT04925544Phase 2
- Endoscopic Surveillance in Serrated Polyposis Syndrome and Low-risk of Advanced NeoplasiaCompletedNCT04906343Not applicable
- Nab-paclitaxel Based TPX Neoadjuvant Chemotherapy for NPC Patients: a Dose-escalation StudyActive, not recruitingNCT04850235Phase 1
- OPHTHALMOLOGIC EVALUATION OF RADIATION-RELATED OPTIC NEUROPATHY FOLLOWING IMAGE GUIDED INTENSITY-MODULATED RADIATION THERAPY (IMRT) FOR NASOPHARYNGEAL CARCİNOMAStatus unknownNCT04724590Not applicable
- Comparison of Methylprednisolone or Methotrexate in the Maintenance Treatment of Nasal PolyposisCompletedNCT04532736Phase 2
- Effect of Vitamin d Deficiency in Chronic Rhinosinusitis With Nasal PolyposisStatus unknownNCT04529668Phase 1
- Saliva Substitute Mouthwash in NPC Survivors With Xerostomia: A Randomized Controlled TrialCompletedNCT04491435Not applicable
- A Study of DC-CIK Immunotherapy in the Treatment of Solid TumorsStatus unknownNCT04476641Phase 2
- Azithromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous PolyposisStatus unknownNCT04454151Phase 4
- Toripalimab Combined With Chemoradiotherapy in Patients With Locoregionally-advanced Nasopharyngeal CarcinomaStatus unknownNCT04446663Phase 2
- Dupilumab Severe Eosinophilic Chronic Sinusitis Without Nasal PolyposisActive, not recruitingNCT04430179Phase 2
- To Evaluate Transoral Flexible Endoscope With Narrow Band Imaging in Nasopharyngeal CancerStatus unknownNCT04419324Not applicable
- Niclosamide for Familial Adenomatous PolyposisStatus unknownNCT04296851Phase 2
- Comparison of Transdermal Fentanyl and Morphine for Oral Mucositis Pain in Nasopharyngeal Cancer PatientsStatus unknownNCT04292990Phase 4
- Applying PET/MR in Oncology - a Prospective ProjectStatus unknownNCT04158414Not applicable
- Sirolimus for Cowden Syndrome With Colon PolyposisCompletedNCT04094675Phase 2
- Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal CarcinomaCompletedNCT04004871Phase 2
- Cell-free Tumor DNA in Head and Neck Cancer PatientsStatus unknownNCT03942380Not applicable
- Docetaxal & Cisplatin vs LDFRT + Docetaxal & Cisplatin in Locally Advanced NPCStatus unknownNCT03890185Phase 2
- IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.Status unknownNCT03854838Phase 2
- MUTYH-associated PolyposisStatus unknownNCT03847532Not applicable
- GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT03840421Phase 3
- Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal CarcinomaStatus unknownNCT03837808Phase 3
- Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPCActive, not recruitingNCT03813394Phase 1/2
- Effect of EPA-FFA on Polypectomy in Familial Adenomatous PolyposisActive, not recruitingNCT03806426Phase 3
- 3DV+TPS Applied to Radiotherapy for Nasopharyngeal CarcinomaCompletedNCT03791944Not applicable
- Sintilimab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal CarcinomaStatus unknownNCT03700476Phase 3
- Efficacy and Safety of Budesonide Inhalation Suspension for the Treatment of Chronic Rhinosinusitis With Polyposis.CompletedNCT03687515Phase 3
- Pilot Study of Somatostatin Receptor Imaging in Nasopharyngeal CancerCompletedNCT03670342
- Assessment of Treatment Response of Nasopharyngeal Cancer Using Simultaneous 18F-FDG-PET and MRICompletedNCT03656250
- A Study of Guselkumab in Participants With Familial Adenomatous PolyposisCompletedNCT03649971Phase 1
- PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal CarcinomaStatus unknownNCT03619824Phase 2
- Appaconitine Patch for Oral Mucositis Pain Caused by Chemoradiotherapy in Patients With Nasopharyngeal CancerStatus unknownNCT03518489Not applicable
- Personalized Surveillance Protocol for Serrated Polyposis SyndromeCompletedNCT03450889
- Dysphagia Assessment After Swallowing Sparing RadioTherapyCompletedNCT03448341
- PD-1 Antibody Versus Best Supportive Care After Chemoradiation in Locoregionally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT03427827Phase 3
- Endoscopic Evaluation of Duodenal Polyposis in Patients With Familial Adenomatous Polyposis (FAP)CompletedNCT03346980
- Mometasone vs Budesonide in CRS With PolyposisTerminatedNCT03323866Phase 3
- Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT03282617Phase 1
- the Study of Effect of Chronomodulated Chemotherapy on the Dendritic Cells Subsets in the Treatment of Advanced Nasopharyngeal CancerStatus unknownNCT03196869Phase 2
- Maintenance Therapy of Apatinib After Chemoradiotherapy in Metastatic Nasopharyngeal CarcinomaCompletedNCT03180476Phase 2
- Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal CarcinomaCompletedNCT03175939Phase 2
- An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other MalignanciesTerminatedNCT03144661Phase 1
- Adaptive Radiotherapy for Head and Neck CancerCompletedNCT03096808Phase 2
- Measuring Patient-Reported Adverse Events in Oncology Practice Improves Quality of Life in Nasopharyngeal CarcinomaStatus unknownNCT03093649Not applicable
- Atezolizumab and Bevacizumab in Treating Patients With Rare Solid TumorsActive, not recruitingNCT03074513Phase 2
- Turmeric Supplementation on Polyp Number and Size in Patients With Familial Adenomatous Polyposis.Status unknownNCT03061591Phase 2
- A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic SurgeryCompletedNCT03010813Not applicable
- High-activity Natural Killer Immunotherapy for Small Metastases of Nasopharyngeal CancerCompletedNCT03007836Phase 1/2
- A Study of Nasopharyngeal Carcinoma From GuangdongStatus unknownNCT03003182
- A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical ApplicationStatus unknownNCT02980315Phase 1/2
- A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma PatientsStatus unknownNCT02948699Phase 4
- Predictive Factors of Acute Oral Mucositis Induced by Chemo-radiotherapy for Local Advanced Nasopharyngeal CarcinomaStatus unknownNCT02945878
- Chronomodulated Chemotherapy Followed by Concurrent Chemo-radiotherapy With IMRT in the Treatment of Advanced Nasopharyngeal CancerStatus unknownNCT02937519Phase 2
- EpCAM CAR-T for Treatment of Advanced Solid TumorsActive, not recruitingNCT02915445Phase 1
- A Trial of Endostar in Patients With Carcinoma of the Head and NeckStatus unknownNCT02902432Phase 2
- ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following RadiotherapyTerminatedNCT02874651Phase 2
- Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal PolyposisCompletedNCT02784262Phase 2
- Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Surveillance ProgramCompletedNCT02747862
- Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRTStatus unknownNCT02735317Phase 2
- Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRTStatus unknownNCT02729324Phase 2
- Small Bowel Endoscopic Evaluation in Familial Adenomatous Polyposis (FAP)Status unknownNCT02656134
- Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal CarcinomaStatus unknownNCT02627807Not applicable
- A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal CancerCompletedNCT02608073Phase 2
- Endocuff for Surveillance of Serrated Polyposis SyndromeCompletedNCT02592603Not applicable
- Reactivating NK Cells in Treating Refractory Head and Neck CancerStatus unknownNCT02507154Phase 1/2
- The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC PatientsCompletedNCT02505139
- Hyperfractionated Intensity-modulated Radiotherapy (IMRT) Versus Conventional Fraction IMRT for Patients With Loco-regionally Recurrent Nasopharyngeal Carcinoma.Status unknownNCT02456506Not applicable
- A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal CarcinomaCompletedNCT02444949Phase 2
- Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal CarcinomaCompletedNCT02360501Phase 2
- Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted VersionStatus unknownNCT02354560Phase 4
- Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer PatientsActive, not recruitingNCT02253238Not applicable
- Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal CarcinomaStatus unknownNCT02250599Phase 2
- Hemoglobin, Neutrophil to Lymphocyte Ratio and Platelet Count Improve Prognosis Prediction in Nasopharyngeal CarcinomaStatus unknownNCT02211677
- Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous PolyposisStatus unknownNCT02175914Phase 4
- Parotid-sparing IMRT for Nasopharyngeal CancerCompletedNCT02149641
- Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal CarcinomaCompletedNCT02113423Not applicable
- Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CWCompletedNCT02113202Phase 1
- Nelfinavir for the Treatment of Gammaherpesvirus-Related TumorsTerminatedNCT02080416Early Phase 1
- Swallowing Exercises for Nasopharyngeal Cancer After Radiation TherapyCompletedNCT01937793Not applicable
- Recombinant Human Granulocyte Macrophage Colony Stimulating Factor(rhGM-CSF) Treating Oral MucositisStatus unknownNCT01806272Phase 2
- A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal CarcinomaCompletedNCT01800071Phase 1
- The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRTCompletedNCT01797900Phase 2
- A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine RegimensStatus unknownNCT01762514Phase 2
- Dose-finding Study of Abraxane in Combination With Cisplatin to Treat Advanced Nasopharyngeal CarcinomaStatus unknownNCT01735409Phase 1/2
- Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis PatientsCompletedNCT01604564
- Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal CarcinomaCompletedNCT01528618Phase 3
- Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.CompletedNCT01469429Phase 1/2
- Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and AsthmaCompletedNCT01393340Phase 2
- Assessment of New Radiation Oncology Technologies and TreatmentsCompletedNCT01379872
- Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement UltrasonographyStatus unknownNCT01347424Phase 2
- Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal CancerStatus unknownNCT01312311Phase 2
- Environmental and Genetic Determinants of NPCTerminatedNCT01257100
- Modified Vaccinia Ankara (MVA) Vaccine StudyCompletedNCT01256853Phase 1
- A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)WithdrawnNCT01245816Phase 3
- Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional TherapyCompletedNCT01094405Phase 2